https://genflowbio.com/ 2026-09-09T20:08:23+00:00 1.0 daily https://genflowbio.com/vacancy/senior-scientist/ 2024-07-12T14:42:34+00:00 0.8 yearly https://genflowbio.com/team/dr-georges-coppin/ 2026-06-03T17:26:31+00:00 0.8 monthly https://genflowbio.com/team/gad-berdugo/ 2026-01-28T07:31:05+00:00 0.8 monthly https://genflowbio.com/team/dr-e-leire/ 2024-10-08T09:11:10+00:00 0.7 yearly https://genflowbio.com/team/dr-mary-e-rinella-md/ 2024-05-02T09:59:12+00:00 0.7 yearly https://genflowbio.com/team/professor-dr-sven-francque/ 2024-05-02T09:58:32+00:00 0.7 yearly https://genflowbio.com/team/dr-manlio-vinciguerra/ 2024-05-02T09:57:56+00:00 0.7 yearly https://genflowbio.com/team/dr-matthew-hirschey/ 2024-05-02T09:57:14+00:00 0.7 yearly https://genflowbio.com/team/dr-eric-verdin/ 2024-05-02T09:56:38+00:00 0.7 yearly https://genflowbio.com/team/dr-vera-gorbunova/ 2024-05-02T09:55:55+00:00 0.7 yearly https://genflowbio.com/team/dr-yassine-bendiabdallah/ 2026-06-22T15:31:51+00:00 0.7 yearly https://genflowbio.com/team/dr-guy-charles-fanneau-de-la-horie/ 2026-06-22T15:32:27+00:00 0.7 yearly https://genflowbio.com/team/tamara-joseph/ 2026-06-22T15:30:45+00:00 0.7 yearly https://genflowbio.com/team/dr-eric-leire/ 2024-10-08T09:11:24+00:00 0.7 yearly https://genflowbio.com/shareholder_document/genflow-meets-primary-endpoint-in-slab-clinical-trial/ 2026-09-09T20:02:20+00:00 0.8 daily https://genflowbio.com/shareholder_document/progress-across-sirt6-patent-portfolio/ 2026-08-03T08:09:53+00:00 0.7 monthly https://genflowbio.com/shareholder_document/mid-year-operational-and-corporate-summary-13-july-2026/ 2026-07-13T14:55:13+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-biosciences-final-results-may-2026/ 2026-06-23T09:59:07+00:00 0.7 monthly https://genflowbio.com/shareholder_document/exercise-of-warrants-and-issue-of-equity/ 2026-06-23T09:57:17+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-announces-participation-at-bio-international-convention-2026/ 2026-06-22T12:10:00+00:00 0.7 monthly https://genflowbio.com/shareholder_document/company-to-present-at-animal-longevity-summit-2026/ 2026-06-19T09:21:03+00:00 0.7 monthly https://genflowbio.com/shareholder_document/gm-proxy-form-june-2026/ 2026-06-04T05:58:03+00:00 0.7 monthly https://genflowbio.com/shareholder_document/gm-notice-june-2026/ 2026-06-04T05:58:02+00:00 0.7 monthly https://genflowbio.com/shareholder_document/annual-financial-statements-31-december-2025-2/ 2026-04-30T13:59:24+00:00 0.7 monthly https://genflowbio.com/shareholder_document/expansion-of-confidentiality-agreements-with-tier-1-animal-health-companies/ 2026-04-28T12:48:55+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-biosciences-enters-strategic-technology-collaboration-with-acuitas-therapeutics/ 2026-04-20T15:05:48+00:00 0.7 monthly https://genflowbio.com/shareholder_document/international-patent-publication-expands-protection-for-sirt6-based-muscular-disease-program/ 2026-04-13T12:26:22+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-reports-sustained-safety-and-efficacy-three-months-post-dosing-in-slab-trial/ 2026-04-08T15:35:19+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-voting-rights/ 2026-03-31T13:29:03+00:00 0.7 monthly https://genflowbio.com/shareholder_document/receipt-of-first-tranche-of-e4-million-non-dilutive-funding-from-wallonia-region-for-gf-1002-development/ 2026-03-02T09:05:09+00:00 0.7 monthly https://genflowbio.com/shareholder_document/positive-preliminary-interim-results-from-slab-clinical-trial-of-sirt6-gene-therapy-in-aged-dogs/ 2026-02-13T15:24:47+00:00 0.7 monthly https://genflowbio.com/shareholder_document/gm-proxy-february-2026-2/ 2026-02-11T17:58:26+00:00 0.7 monthly https://genflowbio.com/shareholder_document/gm-notice-february-2026-2/ 2026-02-11T17:57:59+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genf-approval-of-4-million-wallonia-and-2026-priorities/ 2026-01-29T08:51:32+00:00 0.7 monthly https://genflowbio.com/shareholder_document/a-review-of-an-exciting-2025-2/ 2026-01-29T08:50:03+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-appoints-a-new-chairman-to-accelerate-corporate-and-rd-expansion/ 2026-01-20T17:39:06+00:00 0.7 monthly https://genflowbio.com/shareholder_document/completion-of-dosing-phase-of-canine-gene-therapy/ 2025-12-18T18:36:08+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-to-attend-healthcare-conference/ 2025-12-18T18:36:44+00:00 0.7 monthly https://genflowbio.com/shareholder_document/total-voting-rights-2025-10/ 2025-12-18T18:38:48+00:00 0.7 monthly https://genflowbio.com/shareholder_document/holdings-in-company-2025-10/ 2025-12-19T15:07:09+00:00 0.7 monthly https://genflowbio.com/shareholder_document/publication-of-second-european-patent-application-sirt6-variant-for-nash/ 2025-10-22T15:29:07+00:00 0.7 monthly https://genflowbio.com/shareholder_document/european-patent-office-2025-recognizes-the-patentability-of-claims-of-sirt-6-variant-patent/ 2025-10-22T15:28:12+00:00 0.7 monthly https://genflowbio.com/shareholder_document/update-on-animal-health-program/ 2025-10-10T05:48:37+00:00 0.7 monthly https://genflowbio.com/shareholder_document/update-equity-issue-and-pdmr-notification/ 2025-10-09T18:03:07+00:00 0.7 monthly https://genflowbio.com/shareholder_document/issue-of-equity-correction/ 2025-10-02T14:00:23+00:00 0.7 monthly https://genflowbio.com/shareholder_document/subscription-of-new-ordinary-shares-warrant-issue-pdmr-dealings/ 2025-10-02T14:00:23+00:00 0.7 monthly https://genflowbio.com/shareholder_document/interim-financial-statements-june-2025/ 2025-10-02T14:00:15+00:00 0.7 monthly https://genflowbio.com/shareholder_document/holdings-in-company-september-2025/ 2025-10-02T14:00:15+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-strengthens-ip/ 2025-10-02T14:00:15+00:00 0.7 monthly https://genflowbio.com/shareholder_document/share-subscription-directors-dealing-and-update/ 2025-10-02T14:00:16+00:00 0.7 monthly https://genflowbio.com/shareholder_document/progression-on-grant/ 2025-10-02T14:00:16+00:00 0.7 monthly https://genflowbio.com/shareholder_document/holdings-in-company-may-2025/ 2025-10-02T14:00:16+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-epo-reach/ 2025-10-02T14:00:16+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-signs-cdas-with-animal-health-companies/ 2025-10-02T14:00:17+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-launches-new-development-program/ 2025-10-02T14:00:17+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-corporate-update-june-2025/ 2025-10-02T14:00:18+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-biosciences-strengthens-pre-clinical-efforts/ 2025-10-02T14:00:18+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-biosciences-plc-secures-support/ 2025-10-02T14:00:18+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-advances-gene-therapy-trial-in-dogs/ 2025-10-02T14:00:19+00:00 0.7 monthly https://genflowbio.com/shareholder_document/clinical-readiness-july-2025/ 2025-10-02T14:00:19+00:00 0.7 monthly https://genflowbio.com/shareholder_document/genflow-biosciences-and-cer-sign-master-service-agreement/ 2025-10-02T14:00:19+00:00 0.7 monthly https://genflowbio.com/shareholder_document/agm-results-june-2025/ 2025-10-02T14:00:20+00:00 0.7 monthly https://genflowbio.com/shareholder_document/250530-total-voting-rights/ 2025-10-02T14:00:20+00:00 0.7 monthly https://genflowbio.com/shareholder_document/250113-tr1-notification-2/ 2025-10-02T14:00:21+00:00 0.7 monthly https://genflowbio.com/shareholder_document/250113-tr1-notification-1/ 2025-09-19T14:52:58+00:00 0.7 monthly https://genflowbio.com/shareholder_document/240410-tr-1-pm/ 2025-09-19T14:52:19+00:00 0.7 monthly https://genflowbio.com/shareholder_document/240409-tr-1-el/ 2025-09-19T14:51:35+00:00 0.7 monthly https://genflowbio.com/shareholder_document/2024-highlights/ 2025-09-19T14:50:09+00:00 0.7 monthly https://genflowbio.com/shareholder_document/form-of-proxy-2025/ 2025-05-22T10:12:16+00:00 0.6 yearly https://genflowbio.com/shareholder_document/notice-of-annual-general-meeting-2025/ 2025-05-22T10:08:30+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-biosciences-announces-progress-of-key-sirt6-patent-application-in-japan/ 2025-05-15T11:48:36+00:00 0.6 yearly https://genflowbio.com/shareholder_document/annual-report-year-ended-31-december-2024/ 2025-05-09T13:56:34+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-biosciences-signs-msa-with-heureka-labs-launching-ai-powered-partnership-in-gene-therapy-research/ 2025-04-17T08:08:45+00:00 0.6 yearly https://genflowbio.com/shareholder_document/director-dealings-march-2025/ 2025-03-28T11:01:59+00:00 0.6 yearly https://genflowbio.com/shareholder_document/institutional-investment-march-2025/ 2025-03-26T11:27:10+00:00 0.6 yearly https://genflowbio.com/shareholder_document/2024-genflow-year-end-letter/ 2025-01-06T12:24:37+00:00 0.6 yearly https://genflowbio.com/shareholder_document/interim-financial-statements-30-june-2024/ 2025-05-08T15:41:08+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-half-year-report-2/ 2024-09-30T08:36:54+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-biosciences-plc-to-present-at-the-life-sciences-investor-forum-september-19th/ 2025-09-19T15:00:40+00:00 0.8 yearly https://genflowbio.com/shareholder_document/genflow-fda-guidance/ 2024-06-27T15:40:33+00:00 0.6 yearly https://genflowbio.com/shareholder_document/agm-results-june-2024/ 2024-06-27T14:09:57+00:00 0.6 yearly https://genflowbio.com/shareholder_document/notice-of-agm-2024/ 2024-06-03T07:11:29+00:00 0.6 yearly https://genflowbio.com/shareholder_document/form-of-proxy-2024/ 2025-05-08T15:34:58+00:00 0.6 yearly https://genflowbio.com/shareholder_document/notice-of-annual-general-meeting-2024/ 2025-05-08T15:34:39+00:00 0.6 yearly https://genflowbio.com/shareholder_document/receipt-of-grant-funding/ 2024-05-30T10:07:30+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-financials-statements-31-december-2023/ 2025-05-08T15:45:44+00:00 0.6 yearly https://genflowbio.com/shareholder_document/holdings-in-company-2/ 2024-05-13T10:09:53+00:00 0.6 yearly https://genflowbio.com/shareholder_document/full-text-of-final-accounts-to-31-december-2023/ 2024-05-13T10:07:26+00:00 0.6 yearly https://genflowbio.com/shareholder_document/final-results-rns-2/ 2024-05-13T10:05:43+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-restoration-of-listing/ 2024-05-13T10:04:08+00:00 0.6 yearly https://genflowbio.com/shareholder_document/temporary-suspension-of-listing-pending-publication-of-annual-financial-report/ 2024-05-13T10:02:23+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-total-voting-rights-announcement/ 2024-05-13T10:00:36+00:00 0.6 yearly https://genflowbio.com/shareholder_document/successful-placing-and-subscription-to-raise-715000/ 2024-04-04T13:04:22+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-biosciences-plc-announces-publication-of-a-key-european-patent-in-partnership-with-university-of-rochester-new-york-et-al/ 2024-03-21T12:51:30+00:00 0.6 yearly https://genflowbio.com/shareholder_document/notification-of-major-holdings/ 2024-03-21T10:25:02+00:00 0.6 yearly https://genflowbio.com/shareholder_document/publication-of-a-key-european-patent/ 2024-03-21T10:24:47+00:00 0.6 yearly https://genflowbio.com/shareholder_document/highlights-key-priorities-for-2024/ 2024-02-01T14:35:25+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-biosciences-plc-2023-year-in-review/ 2024-01-30T09:24:00+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-biosciences-partners-with-revatis-sa-and-exo-biologics/ 2024-01-26T14:03:53+00:00 0.6 yearly https://genflowbio.com/shareholder_document/two-non-dilutive-research-grant-awards/ 2024-01-18T13:57:56+00:00 0.6 yearly https://genflowbio.com/shareholder_document/appointment-of-cap-plus-joint-broker/ 2023-11-08T09:21:23+00:00 0.6 yearly https://genflowbio.com/shareholder_document/interim-financial-statements-30-june-2023/ 2025-05-08T15:34:10+00:00 0.6 yearly https://genflowbio.com/shareholder_document/half-year-results-2/ 2023-09-28T08:37:29+00:00 0.6 yearly https://genflowbio.com/shareholder_document/company-update-2/ 2023-09-21T10:04:56+00:00 0.6 yearly https://genflowbio.com/shareholder_document/notice-of-annual-general-meeting/ 2023-05-16T09:06:00+00:00 0.6 yearly https://genflowbio.com/shareholder_document/agm-notice-june-2023/ 2025-05-08T15:34:46+00:00 0.6 yearly https://genflowbio.com/shareholder_document/form-of-proxy-2023/ 2025-05-08T15:35:11+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-financials-statements-31-december-2022/ 2025-05-08T15:35:40+00:00 0.6 yearly https://genflowbio.com/shareholder_document/application-for-trading-on-us-otcqb-venture-market/ 2023-04-24T07:15:01+00:00 0.6 yearly https://genflowbio.com/shareholder_document/financial-year-end-announcement-2/ 2023-04-24T07:12:08+00:00 0.6 yearly https://genflowbio.com/shareholder_document/company-update-april-2023-2/ 2023-04-04T12:18:58+00:00 0.6 yearly https://genflowbio.com/shareholder_document/holdings-in-company/ 2023-03-22T18:39:09+00:00 0.6 yearly https://genflowbio.com/shareholder_document/interim-financial-statements-30-june-2022/ 2025-05-08T15:40:29+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-half-year-results-2/ 2022-09-30T09:21:48+00:00 0.6 yearly https://genflowbio.com/shareholder_document/pdmr-notifications-4/ 2022-07-20T06:35:18+00:00 0.6 yearly https://genflowbio.com/shareholder_document/pdmr-notifications-3/ 2022-07-19T05:51:49+00:00 0.6 yearly https://genflowbio.com/shareholder_document/board-changes/ 2022-07-12T08:18:20+00:00 0.6 yearly https://genflowbio.com/shareholder_document/results-of-annual-general-meeting/ 2022-06-14T09:30:30+00:00 0.6 yearly https://genflowbio.com/shareholder_document/notice-of-annual-general-meeting-2022/ 2025-05-08T15:36:10+00:00 0.6 yearly https://genflowbio.com/shareholder_document/form-of-proxy-2022/ 2025-05-08T15:36:29+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-ceo-to-participate-in-distinguished-panel-in-the-united-states-2/ 2022-05-18T11:12:34+00:00 0.6 yearly https://genflowbio.com/shareholder_document/company-update-16-may-2022/ 2022-05-16T14:32:38+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-accounts-31-december-2021/ 2025-05-08T15:36:59+00:00 0.6 yearly https://genflowbio.com/shareholder_document/financial-year-end-announcement/ 2022-04-29T04:45:04+00:00 0.6 yearly https://genflowbio.com/shareholder_document/new-research-collaboration-with-the-university-of-rochesters-aging-research-center/ 2022-03-29T05:31:38+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-receives-non-dilutive-grant-research-award-from-the-wallonia-region-rns/ 2022-03-16T12:32:15+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-biosciences-first-day-of-dealings/ 2022-01-17T10:12:46+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-biosciences-prospectus/ 2022-01-17T10:11:49+00:00 0.6 yearly https://genflowbio.com/shareholder_document/genflow-biosciences-itf/ 2022-01-09T17:48:07+00:00 0.6 yearly https://genflowbio.com/publication/transcriptional-control-of-hepatocellular-carcinoma-cells-aggressiveness-by-aav2-8-mediated-delivery-of-human-centenarian-associated-sirt6-n308k-a313s/ 2026-08-31T14:05:33+00:00 0.8 weekly https://genflowbio.com/publication/epigenetic-and-transcriptional-control-of-adipocyte-function-by-centenarian-associatedsirt6-n308k-a313s-mutant/ 2026-08-31T14:03:35+00:00 0.8 weekly https://genflowbio.com/publication/human-centenarian-associated-sirt6-mutants-modulate-hepatocyte-metabolism-and-collagen-deposition-in-multilineage-hepatic-3d-spheroids/ 2026-08-31T14:00:03+00:00 0.8 weekly https://genflowbio.com/publication/sirt6-overexpression-improves-various-aspects-of-mouse-healthspan/ 2024-05-03T16:17:24+00:00 0.6 yearly https://genflowbio.com/publication/the-sirtuin-sirt6-regulates-lifespan-in-male-mice/ 2024-05-03T16:16:20+00:00 0.6 yearly https://genflowbio.com/publication/hormones-reproduction-and-disease-in-the-longest-lived-rodent-the-naked-mole-rat/ 2024-05-03T16:15:44+00:00 0.6 yearly https://genflowbio.com/publication/old-enzymes-new-tricks-sirtuins-are-nad-dependent-de-acylases/ 2024-05-03T16:15:14+00:00 0.6 yearly https://genflowbio.com/publication/role-of-nad-and-mitochondrial-sirtuins-in-cardiac-and-renal-diseases/ 2024-05-03T16:14:39+00:00 0.6 yearly https://genflowbio.com/publication/sirt6-promotes-hepatic-beta-oxidation-via-activation-of-ppar%ce%b1/ 2024-05-03T16:14:01+00:00 0.6 yearly https://genflowbio.com/publication/sirtuin-regulation-of-mitochondria-energy-production-apoptosis-and-signaling/ 2024-05-03T16:13:04+00:00 0.6 yearly https://genflowbio.com/publication/the-sirtuins-oxidative-stress-and-aging-an-emerging-link/ 2024-05-03T16:12:32+00:00 0.6 yearly https://genflowbio.com/publication/metabolic-control-by-sirtuins-and-other-enzymes-that-sense-nad-nadh-or-their-ratio/ 2024-05-03T16:11:59+00:00 0.6 yearly https://genflowbio.com/publication/luigi-fontana-interventions-to-slow-aging-in-humans-are-we-ready/ 2024-05-03T16:11:26+00:00 0.6 yearly https://genflowbio.com/publication/the-nad-sirtuin-pathway-modulates-longevity-through-activation-of-mitochondrial-upr-and-foxo-signaling/ 2024-05-03T16:10:42+00:00 0.6 yearly https://genflowbio.com/publication/epigenetics-and-longevity/ 2024-05-03T16:10:03+00:00 0.6 yearly https://genflowbio.com/publication/sirt6-promotes-dna-repair-under-stress-by-activating-parp1/ 2024-05-03T16:09:16+00:00 0.6 yearly https://genflowbio.com/publication/aging-genes-the-sirtuin-story-unravels/ 2024-05-03T16:08:29+00:00 0.6 yearly https://genflowbio.com/publication/sirtuin-activators-and-inhibitors-promises-achievements-and-challenges/ 2024-05-03T16:07:56+00:00 0.6 yearly https://genflowbio.com/publication/sirt6-links-histone-h3-lysine-9-deacetylation-to-nf-kappab-dependent-gene-expression-and-organismal-life-span/ 2024-05-03T16:05:37+00:00 0.6 yearly https://genflowbio.com/publication/genomic-instability-and-aging-like-phenotype-in-the-absence-of-mammalian-sirt6/ 2024-05-03T16:04:57+00:00 0.6 yearly https://genflowbio.com/publication/sirt6-is-responsible-for-more-efficient-dna-double-strand-break-repair-in-long-lived-species/ 2024-05-03T16:04:15+00:00 0.6 yearly https://genflowbio.com/genflow-biosciences-ceo-welcomes-new-investment-outlines-dog-longevity-trial/ 2025-03-28T10:58:57+00:00 0.7 yearly https://genflowbio.com/genflow-bioscience-named-a-firm-to-watch-in-2024-by-the-guardian/ 2024-06-20T15:01:24+00:00 0.6 yearly https://genflowbio.com/what-is-gene-therapy/ 2024-06-20T15:00:13+00:00 0.8 yearly https://genflowbio.com/what-is-biotechnology/ 2024-06-20T15:02:06+00:00 0.8 yearly https://genflowbio.com/genflow-in-the-top-50-innovator-companies-worldwide-for-2022/ 2024-05-03T13:28:10+00:00 0.6 yearly https://genflowbio.com/types-of-genes/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/premature-aging/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/natural-living/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/how-to-not-be-tired-all-the-time-and-feel-more-energized/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/how-to-combat-aging/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/how-long-do-dogs-live/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/healthspan/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/gene-mutation/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/dna-damage/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/dna-damage-repair/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/bioscience-news/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/age-related-diseases/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/is-there-a-cure-for-old-age/ 2024-05-03T13:28:10+00:00 0.6 yearly https://genflowbio.com/chief-executive-officer-of-genflow-biosciences-interview/ 2024-05-03T13:31:21+00:00 0.7 yearly https://genflowbio.com/an-audience-with-dr-eric-leire/ 2024-05-03T13:31:21+00:00 0.6 yearly https://genflowbio.com/a-disruptive-approach-to-longevity-therapies/ 2024-05-03T13:31:21+00:00 0.7 yearly https://genflowbio.com/brain-fog-how-trauma-uncertainty-and-isolation-have-affected-our-minds-and-memory/ 2024-05-03T13:28:10+00:00 0.8 yearly https://i.guim.co.uk/img/media/d9c4051ed6f553e5f3612f19d0f7e7194e9f248e/0_1310_3100_1859/master/3100.jpg?width=465&quality=45&auto=format&fit=max&dpr=2&s=e2b1e0590952612d670f6bd7831e9833 Brain fog has resulted from “degraded social interaction” https://genflowbio.com/why-do-some-animals-live-extraordinarily-long-lives-and-can-humans-benefit-from-studying-them/ 2024-05-03T13:28:56+00:00 0.8 yearly https://geneticliteracyproject.org/wp-content/uploads/2021/05/https-www-inaturalist-org-photos-.jpg https://geneticliteracyproject.org/wp-content/uploads/2021/05/lalbatross-wisdom-weedmandan-scaled.jpg https://geneticliteracyproject.org/wp-content/uploads/2021/05/screenshot-pm-8.png screenshot pm https://geneticliteracyproject.org/wp-content/uploads/2021/05/xl-.jpg https://genflowbio.com/want-30-more-healthy-years-of-life-elephants-show-us-the-way/ 2024-05-03T13:28:10+00:00 0.8 yearly https://genflowbio.com/eric-leire-on-spotify-podcast/ 2024-05-03T13:28:23+00:00 0.6 yearly https://genflowbio.com/how-long-can-we-live/ 2024-05-03T13:28:23+00:00 0.8 yearly https://genflowbio.com/humans-could-live-to-150-say-scientists/ 2021-06-14T22:16:32+00:00 0.8 yearly https://genflowbio.com/longer-healthier-life/ 2024-05-03T13:28:23+00:00 0.8 yearly https://genflowbio.com/media-assets/ 2026-05-01T17:47:55+00:00 0.9 yearly https://genflowbio.com/wp-content/uploads/2021/04/Dr-Eric.jpg Dr Eric https://genflowbio.com/wp-content/uploads/2021/06/eric_leire-e1714656979999.jpg Eric leire https://genflowbio.com/careers/ 2024-07-12T09:56:08+00:00 0.7 yearly https://genflowbio.com/no-access/ 2024-05-28T14:43:54+00:00 0.7 yearly https://genflowbio.com/investors/major-shareholders/ 2024-05-03T13:25:20+00:00 0.7 yearly https://genflowbio.com/investors/committees/ 2026-07-30T08:42:25+00:00 0.9 yearly https://genflowbio.com/investors/esg/ 2025-01-07T09:28:11+00:00 0.9 yearly https://genflowbio.com/investors/rns/ 2025-08-20T15:59:54+00:00 0.7 yearly https://genflowbio.com/investors/advisors/ 2026-02-11T17:59:46+00:00 0.8 yearly https://genflowbio.com/investors/corporate-governance/ 2024-05-03T11:23:38+00:00 0.8 yearly https://genflowbio.com/investors/ 2026-07-28T15:12:30+00:00 0.7 yearly https://genflowbio.com/wp-content/uploads/Pages-from-Genflow-Jan-2026-Fact-Sheet-cover.webp Pages from Genflow Jan 2026 Fact Sheet cover https://genflowbio.com/publications/ 2025-08-20T15:39:20+00:00 0.7 yearly https://genflowbio.com/science/clinical-programs/ 2026-06-22T15:25:03+00:00 0.9 yearly https://genflowbio.com/science/product-pipeline/ 2026-08-31T12:54:31+00:00 0.7 yearly https://genflowbio.com/wp-content/uploads/Genflow-Science-Pipeline-Chart-original-2026-08-v1.webp Genflow Science Pipeline Chart original 2026 08 v1 https://genflowbio.com/contact/ 2026-07-16T17:11:15+00:00 0.7 yearly https://genflowbio.com/wp-content/uploads/Genflow-london-sm.webp Genflow London Sm https://genflowbio.com/wp-content/uploads/2021/04/Genflow-brussels.jpg Genflow Brussels https://genflowbio.com/wp-content/uploads/2023/11/Stamford_Connecticut_Skyline_Aug_2017_sm.jpg Stamford Connecticut Skyline Aug 2017 Sm https://genflowbio.com/science/ 2026-06-22T15:26:24+00:00 0.8 yearly https://genflowbio.com/leadership/ 2024-05-02T13:51:09+00:00 0.7 yearly https://genflowbio.com/about/ 2026-06-03T11:16:35+00:00 0.9 yearly https://genflowbio.com/wp-content/uploads/icon-intellectual-curiosity.svg Icon Intellectual Curiosity https://genflowbio.com/wp-content/uploads/icon-collaborative.svg Icon Collaborative https://genflowbio.com/wp-content/uploads/icon-innovative.svg Icon Innovative https://genflowbio.com/wp-content/uploads/icon-ethical.svg Icon Ethical https://genflowbio.com/wp-content/uploads/icon-considerate.svg Icon Considerate https://genflowbio.com/wp-content/uploads/icon-couragious.svg Icon Couragious https://genflowbio.com/team-category/scientific-advisory-board/ 0.4 weekly https://genflowbio.com/team-category/executive-team/ 0.4 weekly https://genflowbio.com/team-category/board-of-directors/ 0.4 weekly